Increased levels of GFAP in the cerebrospinal fluid in three subtypes of genetically confirmed Alexander disease

Neuropediatrics

Volumn 36, Issue 5, 2005, Pages 319-323

  Kyllerman, M ^a   Rosengren, L ^b   Wiklund, L M ^a   Holmberg, E ^b  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alexander disease; CSF analysis; GFAP

Indexed keywords

CATECHOLAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; PREDNISOLONE;

ADULT; ALEXANDER DISEASE; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CASE REPORT; CATECHOLAMINE URINE LEVEL; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MISSENSE MUTATION; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCHOOL CHILD; SCREENING TEST; TREMOR; URINALYSIS;

ADULT; ALBUMINS; ALEXANDER DISEASE; BRAIN; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; S100 PROTEINS; TOMOGRAPHY, X-RAY;

EID: 27144488373     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872876     Document Type: Article

References (14)

1. Blennow K, Wallin A, Ågren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 1995; 26: 231-245
2. Blennow M, Hagberg H, Rosengren L. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res 1995; 37: 260-264
3. Brockmann K, Dechent P, Meins M, Haupt M, Sperner J, Stephani U, Frahm J, Hanefeld F. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 2003; 250: 300-306
4. Ehlers S, Kyllerman M, Rosengren L. Analysis of glial fibrillary acidic protein in the cerebrospinal fluid of children investigated for encephalopathy. Neuropediatrics 1994; 24: 129-133
5. Johnson AB, Brenner M. Alexander's disease: clinical, pathologic, and genetic features. J Child Neurol 2003; 18: 625-632
6. Johnson AB. Alexander disease: A review and the gene. Int J Dev Neurosci 2002; 20: 391-394
7. Kristiansdottir R, Uvebrant P, Rosengren L. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities. Neuropediatrics 2001; 32: 307-312
8. Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci 2004; 61: 369-385
9. Rosengren LE, Wikkelsø C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Meth 1994; 51: 197-204
10. Rosengren LE, Karlsson J-E, Karlsson J-O, Persson LI, Wikkelsø C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament proteins in CSF. J Neurochem 1996; 67: 2013-2018
11. Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, Cree B, Ruyle SZ, Banwell B, D'Hooghe M, Siebert JR, Rolf CM, Cox H, Reddy A, Gutierrez-Solana LG, Collins A, Weller RO, Messing A, van der Knaap MS, Brenner M. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005; 57: 310-326
12. Lortie A, Lesage J, Montplaisir J, Brais B, Cossette P. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by a mutation in the glial fibrillar acid protein gene. Arch Neurol 2003; 60: 1307-1312
13. Studahl M, Rosengren L, Günther G, Hagberg L. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tickborne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 2000; 247: 636-642
14. Stumpf E, Masson H, Duquetta A, Berthelet F, McNabb J, Lortie A, Lesague J, Montpalisir J, Brais B, Cossette P. Adult Alexander disease with autosomal dominant transmission. Arch Neurol 2003; 60: 1307-1312